Immediate Impact
28 standout
Citing Papers
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
2024 Standout
Response and Resistance to BCR-ABL1-Targeted Therapies
2020 Standout
Works of T. Karrison being referenced
Safety and Efficacy of a Randomized Phase I Trial to Evaluate Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-small Cell Lung Cancer (COSINR Study)
2020
Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| T. Karrison | 10 | 2 | 3 | 21 | 12 | 6 | 38 | |
| Benedetta Cambò | 9 | 1 | 27 | 17 | 5 | 44 | ||
| Laurent Garderet | 6 | 2 | 42 | 24 | 4 | 45 | ||
| Laura Stenson | 10 | 1 | 37 | 32 | 4 | 45 | ||
| Gudrun Goehring | 4 | 2 | 32 | 10 | 7 | 39 | ||
| Maurizio Cantini | 3 | 1 | 21 | 19 | 9 | 33 | ||
| Manuela Marega | 2 | 8 | 6 | 25 | 14 | 6 | 52 | |
| Frédéric Millot | 6 | 3 | 3 | 18 | 7 | 9 | 39 | |
| Giovanni Pisapia | 11 | 3 | 2 | 40 | 13 | 6 | 59 | |
| R Mataix | 9 | 2 | 24 | 8 | 8 | 33 | ||
| Ming Lin | 3 | 3 | 7 | 12 | 10 | 9 | 30 |
All Works
Loading papers...